- Home
- Products
- Customized FluoroAb™
- C5
- Anti-C5 MAb (Clone 26)-iFluor® 350 Succinimidyl Ester
Anti-C5 MAb (Clone 26)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS110)
This product is comprised of an Humanized Anti-C5 IgG2/G4-kappa antibody (Clone 26) labeled with iFluor® 350 Succinimidyl Ester. iFluor® 350 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 345/450 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Humanized Anti-C5 IgG2/G4-kappa antibody (Clone 26)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CEACAM5 MAb (Clone 11)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5654)
- Anti-CD28 MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6934)
- Anti-KDR MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6688)
- Anti-CD37 MAb (Clone 9)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16425)
- Anti-TNF MAb (Clone 4)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS705)
- Anti-TNFRSF8 MAb (Clone 3)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4974)
- Anti-CD19 MAb (Clone 32)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14780)
- Anti-IL23A MAb (Clone 7)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7486)
- Anti-SELP MAb (Clone 2)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10715)
- Anti-MIF MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4699)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS110. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-738 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-734 | Anti-C5 (Pexelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-728 | Anti-C5 (Eculizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-732 | Anti-C5 (Eculizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-737 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.